Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal title
JPGN ReportsDate Published
2022-02Publication Volume
3Publication Issue
1Publication Begin page
e152
Metadata
Show full item recordAbstract
In addition to the severe impact of acute respiratory disease during the SARS-CoV-2 pandemic, the issue of “Long COVID” illness has impacted large numbers of patients following the initial infection. Wide ranges of Long Covid incidence have been reported, ranging from 30 to 87%. Long COVID has a variety of clinical manifestations, including gastrointestinal symptoms. Here, we report a case of persistent abdominal pain, 3 months following a SARS-CoV-2 diagnosis, associated with chronic colonic inflammation and the presence of mucosal SARS-CoV-2 virions.Citation
Arostegui, Dalia MD; Castro, Kenny MD; Schwarz, Steven MD; Vaidy, Katherine MD; Rabinowitz, Simon MD; Wallach, Thomas MD. Persistent SARS-CoV-2 Nucleocapsid Protein Presence in the Intestinal Epithelium of a Pediatric Patient 3 Months After Acute Infection. JPGN Reports: February 2022 - Volume 3 - Issue 1 - p e152 doi: 10.1097/PG9.0000000000000152DOI
10.1097/pg9.0000000000000152ae974a485f413a2113503eed53cd6c53
10.1097/pg9.0000000000000152
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International